The method used to evaluate the response of osteosarcoma to preoperative chemotherapy before specimen resection is still unclear. The purpose of this study was to identify factors that contribute to overall survival (OS) and to discuss their roles in making a decision regarding Enneking surgical margins. Patients (109) with pathologically confirmed Enneking stage IIB osteosarcoma were retrospectively analyzed. Univariate and multivariate survival analyses were performed. Patient characteristics and chemotherapyinduced contrast-enhanced MRI changes were considered as potential factors. Changes in the tumor volume and the relative necrosis ratio measured by MRI were independent risk factors predicting the OS of patients who underwent limb-salvage surgery. For those in whom the tumor volume had decreased (VolRatio <1) or the relative necrosis ratio had increased by at least 10% (NecRatioInc !0. Osteosarcoma is a primary malignant tumor of the bone in which malignant cells produce osteoid.
Osteosarcoma is a primary malignant tumor of the bone in which malignant cells produce osteoid. 1 The annual incidence of osteosarcoma is approximately 10-26 per million adolescents worldwide. 2 With the combination of neoadjuvant chemotherapy and surgical resection, the 5-year overall survival (OS) rate has increased to 60-70%. [3] [4] [5] Currently, limb-salvage surgery (LSS) is preferred over amputation for osteosarcoma treatment, as the two procedures show similar survival rates. [6] [7] [8] More importantly, except for tumors of the tibia, LSS can result in better function and quality of life. 9, 10 According to the NCCN guidelines, 11 for osteosarcoma, wide margin excision should be achieved. Enneking et al. 12 defined the surgical margins as intralesional, marginal, wide, and radical in accordance with the location of their resection plane. Although marginal, wide, and radical margins may all be tumorfree, the residual reactive tissue at a marginal margin often contains satellites, and the residual normal intracompartmental tissue beyond a wide margin occasionally contains skip lesions. A recent study conducted by Jeys et al. 13 indicated that patients with <2 mm margins and good histological responses (over 90% tumor necrosis rate) had similar survival to those with >2 mm margins, but the difference between those with poor histological responses (under 90% tumor necrosis rate) was 84% for >2 mm versus 76.1% for <2 mm. In addition, there is sufficient evidence to argue that a good histological response to chemotherapy is an independent prognostic factor in long-term follow-up. [14] [15] [16] As a closer surgical margin increases the indications for LSS, it is critical to identify prognostic factors that are available before the definitive operation. The histological necrosis rate is an important parameter for evaluating the chemotherapy response. However, it can only be obtained post-operatively, which hardly helps orthopedic oncologists to decide between LSS and amputation.
Pan et al. 17 studied chemotherapy-induced MRI changes, suggesting that changes in tumor volume, peritumoral edema, boundaries around the extraosseous component, and hemorrhage were associated with chemotherapy. de Baere et al. 18 reported that the nonenhanced area on contrast-enhanced MRI had a high correlation with histological necrosis, and Holscher et al. 19 revealed that changes in tumor volume and the signal intensity of the extraosseous tumor component (especially the extraosseous non-enhanced signal intensity) were the only two parameters that were significantly correlated with histological response. However, the method used to estimate the prognosis of a marginal margin combined with a good response and to plan the resection plane is still unclear.
The purpose of this study was to identify factors that contribute to OS and to discuss their roles in making decisions regarding surgical margins. Chemotherapy-induced contrast-enhanced MRI changes were considered as potential factors.
PATIENTS AND METHODS

Selection Criteria
This retrospective cohort was retrieved from our database, and all patients were included if they met the following criteria: (i) a diagnosis of a primary high-grade conventional osteosarcoma in an extremity; (ii) Enneking IIB grade disease (involved extraosseous compartment, and no existence of metastasis); (iii) treated between January 1, 2005, and December 31, 2016, at our institution; (iv) treated with IOR-N4 neoadjuvant chemotherapy as well as amputation or LSS; (v) static and fat-suppression contrast-enhanced MRI scans before and after the preoperative chemotherapy; and (vi) surgical margins reviewed and reported by surgeons and pathologists together. From a total of 112 eligible patients, those with other fatal diseases (n ¼ 1, leukemia) and patients who were diagnosed at our institution but underwent final surgery at another hospital (n ¼ 2) were excluded.
Patient Characteristics
A total of 109 participants matched the selection criteria. The mean age at diagnosis was 23.0 years (SD, 12.6; range, 7-74 years); 66 patients were males (60.6%). The mean follow-up period was 58.1 months (SD, 40.8; range, 6-152 months), and the mean follow-up period for surviving patients was 69.7 months (SD, 41.3; range, 6-152 months). The most common anatomical tumor sites were the distal femur (n ¼ 50 [45.9%]) followed by the proximal tibia (n ¼ 36 [33.0%]). Five patients (4.6%) presented with a pathological fracture. LSS (endoprosthetic or biological reconstruction) was the most commonly performed surgical procedure (85.3%).
Surgical Margins and Histological Response to Chemotherapy
During this period, patients received neoadjuvant chemotherapy according to the IOR-N4 protocol (cisplatin, doxorubicin, methotrexate, and ifosfamide). 20 The resected specimens were examined by pathologists for surgical margin and histological response. An intralesional margin is created when the resection is located within the tumor, whereas a marginal margin is created when the resection is performed within the reactive zone surrounding the tumor. A wide surgical margin is achieved when the tumor is resected with a cuff of normal tissue. For the surgical margin to be classified as radical, the entire bone and the soft-tissue compartments that were involved by the tumor must be removed. Margin determination may be estimated by inspection of the cut surface of either the bone or soft tissue. Specimens from questionable areas must be taken for histologic study to verify whether non-neoplastic tissue at a margin is reactive or normal. The majority of tumors were resected widely (n ¼ 71 [65.1%]). Meanwhile, 33 tumors (30.3%) were excised with a marginal margin, and five patients (4.6%) that underwent amputation achieved a radical margin ( Table 1) .
The response to chemotherapy of the tumor was assessed according to a method reported by Rosen and Huvos. 21 According to the size of the tumor, all the specimens were divided into 30-70 tissue samples, and representative tissue sections of all the regions were examined to determine the tumor necrosis rate. The response is classified as "poor" (less than 90% tumor necrosis), "good" (90-99% tumor necrosis), or "total" (no viable cells remaining).
Variables Measured by Contrast-Enhanced MRI
We collected T1-weighted fat-suppression coronal slices of the lesions with gadolinium-DTPA contrast enhancement, as previously described by Gronemeyer et al. 22 The tumor volume (VolPre, VolPost), extraosseous component volume (ExtVolPre, ExtVolPost), and extraosseous non-enhanced component volume (NecVolPre, NecVolPost) were measured before and after the preoperative chemotherapy by a radiologist who was blinded to oncological outcome data (Fig. 1) . The method used to determine volume was previously described by Laux et al. 23 The total tumor volume corresponds to the sum of all volumes of interest multiplied by the slice thickness. After the absolute volumetry was performed, the relative size was calculated. To study the correlation between the relative necrosis ratio measured by MRI and histological tumor necrosis rate, the intraosseous non-enhanced component volume was also measured. We defined the ratio of VolPost and VolPre as VolRatio (similar to ExtVolRatio), the ratio of NecVolPre and ExtVolPre as NecRatioPre (similar to NecRatioPost), and the difference between NecRatioPost and NecRatioPre as NecRatioInc (Table 2) .
Statistical Analysis
Descriptive statistics were used to display demographic data. For significance testing in independent samples not following a normal distribution, the Mann-Whitney-Wilcoxon test was applied. The local recurrence-free survival (LRFS), metastasis-free survival (MFS) and OS were calculated by the Kaplan-Meier method with the log-rank test. Time zero was defined as the date of diagnosis and censored at the date of the last follow-up. All patient characteristics and volumetric variables underwent subsequent multivariate Cox proportional hazard analysis to identify predictors of OS, and a forward stepwise likelihood ratio method was applied. Statistical analysis was performed using SPSS version 24.0 (IBM, NY) and R version 3.4.0 (The R Foundation). (Fig. 2) .
The 5-year OS rate (Table 1) was not related to the patient's gender, age, tumor site, pathological fracture at presentation, or surgical margin. Patients who underwent LSS had a better prognosis than those who underwent amputation (5-year OS, 70.7% vs. 46.9%; p ¼ 0.013). According to the histological response to preoperative chemotherapy, the 5-year OS rate was 40.7% for poor responders and 90.9% for good responders. The difference between patients with a good and poor response was statistically significant (p ¼ 0.023).
Post-Chemotherapy Relative Necrosis Ratio Measured by MRI and Histological Tumor Necrosis Rate
The pathology department in our hospital did not routinely report the histological necrosis rate, so we failed to analyze the correlation between MRI changes and histological response in the full population. Out of the 109 patients, the histological tumor necrosis rate was reported for 40 resected specimens, and all 40 (Table 3) .
Variate Analysis of the OS of the LSS Group
The same univariate and multivariate analysis process was performed on patients who underwent LSS (Table 4 ).
In contrast, significantly greater OS was found for wide margins than marginal margins (5-year OS, 81.5% vs. 50.9%; p ¼ 0.008). VolRatio (HR, 1.941; p < 0.001) and NecRatioInc (HR, 0.0051; p < 0.001) were independent predictive factors of OS. Harrell's C statistic of the multivariate Cox model including VolRatio and NecRatioInc was 0.818, indicating a strongly reasonable model. 24 No significant interaction between VolRatio and NecRatioInc was found in the multivariate analysis (P ¼ 0.997).
Changes in Tumor Volume and Surgical Margin
For patients who underwent LSS whose tumor volume was reduced (VolRatio <1), there was no significant difference in OS (10-year OS, 83.6% vs. 77.8%; p ¼ 0.327) between wide margins (4 in 41 died) and marginal margins (3 in 17 died). Meanwhile, for patients with VolRatio !1, the 10-year OS rate for wide and marginal margins was 64.2% and 23.8%, respectively (p ¼ 0.051) (Fig. 5) .
Relative Necrosis Ratio Measured by MRI and Surgical Margin
For patients who underwent LSS whose relative necrosis ratio increased by at least 10% (NecRatioInc !0.1), there was no significant difference in OS (10-year OS, 95.0% vs. 90.0%; p ¼ 0.424) between wide margins (1 in 33 died) and marginal margins (1 in 16 died). For patients with NecRatioInc <0.1, wide margins showed an advantage in OS compared with marginal margins (10-year OS, 57.6% vs. 25.0%; p ¼ 0.024) (Fig. 6) . 
MRI PREDICTS PROGNOSIS OF MARGINS
261
DISCUSSION
Since Enneking introduced the surgical margin system, 12 LR and poor survival have been considered mainly consequences of inadequate margins. In the present study, the OS of the whole cohort was not related to the surgical margin, despite a borderlinesignificant p-value (0.073). Considering that 68.8% (11/ 16) of patients who underwent amputation and achieved a wide margin had a poor prognosis, we looked into the baseline characteristics of these patients. There was a significant difference in postchemotherapy tumor volume (mean, 817 vs. 189 ml; p < 0.001) between patients who underwent amputation and LSS, which indicated that patients who underwent amputation had a more severe condition. Thus, we assumed that the risk of a wide margin had been overestimated. Therefore, it was necessary to understand whether marginal and wide margins had different influences on survival in patients who underwent LSS. Our results revealed a significant increase in the HR of survival in patients with a marginal margin versus a wide margin (p ¼ 0.011), suggesting that a marginal margin could increase the risk of death.
Surgical margin lost its statistical significance in the subsequent multivariate analysis, which is in contrast with well-established knowledge. 10, 25 One possible reason is that these studies magnified the effect of the intralesional margin, which is microscopic positive and associated with the worst prognosis. 26 The effect of a marginal margin on the survival of osteosarcoma needs to be confirmed because of the inconsistent results presented by current studies. [27] [28] [29] Bertrand et al. concluded that the likelihood of increasing LR and mortality was associated with margin status rather than margin width. 30 A marginal margin would not increase the risk of LR and death if it is free of tumor contamination. 30 Therefore, we analyzed the correlation of surgical margin with other variables. A strong correlation was found between a marginal margin and a larger tumor (p < 0.001-0.01).
We investigated the effect of tumor volume on OS, and a larger post-chemotherapy tumor volume was identified as a factor of a poor prognosis (VolPost, p ¼ 0.001; ExtVolPost, p ¼ 0.002). Meanwhile, pre-chemotherapy tumor volume was irrelevant to survival (VolPre, p ¼ 0.495; ExtVolPre, p ¼ 0.453). These results suggest that the response to chemotherapy is more influential than the local condition. This hypothesis was confirmed by the multivariate analysis, with only VolRatio and NecRatioInc remaining in the fitting model.
There were several options for VolRatio and NecRatioInc cutoffs in the analysis of OS and surgical margin. RECIST v1.1 recommends at least a 30% decrease (PR) or 20% increase (PD) in the sum of the diameters of target lesions, 31 which is difficult to apply to primary lesions in osteosarcoma. Another widely used criterion was classified as follows: <0.95 as decreased, 0.95-1.05 as stable, and >1.05 as increased. 29 This trichotomous classification is reasonable and practicable in clinical experience, but dividing our patients (33 patients with marginal margins) into three groups would remarkably reduce the statistical power. Thus, we desired a dichotomous classification drawing from the design of the trichotomous classification (with cutoff values limited to increments of 0.05). For patients who underwent LSS and having VolRatio <1.05, the 10-year OS rate for wide and marginal margins was 84.3% versus 72.0% (p ¼ 0.096). Due to the limitation of the sample size, borderline p values should be considered unreliable. Facing such an important clinical question, a conservative decision should be made, and we applied an a level of 0.1 in this situation. Then, assigning VolRatio <1, the p-value of the log-rank test comparing wide and marginal margins in OS was 0.327. For patients with VolRatio !1, the 10-year OS rate for wide and marginal margins was 64.2% and 23.8%, respectively. We considered this difference to have clinical significance, although the log-rank p-value was 0.051. Using a similar process, for patients who underwent LSS and having NecRatioInc !0.05, the 10-year OS rate for wide and marginal margins was 92.3% versus 61.1% (p ¼ 0.017), suggesting that a marginal margin combined with this NecRatioInc level was still related to a poor prognosis.
There are several limitations in this study. First, although extraosseous non-enhanced signal intensity is correlated significantly with histological response, it has high specificity but low sensitivity, 32 which explains the differences between the post-chemotherapy relative necrosis ratio as measured by MRI and the histological tumor necrosis rate. Second, this is a single-center retrospective study of 109 patients, which ensures treatment consistency but potentially limits the external validity of the findings. Third, contrast-enhanced MRI would be better assessed by a radiologist, which limits the clinical application of the data.
In conclusion, this study investigated chemotherapy-induced MRI changes in patients with osteosarcoma and the influences of surgical margins. We found no significant difference in OS between wide and marginal margins for patients who underwent LSS whose tumor volume had a reduced volume (VolRatio <1) or a relative necrosis ratio increased by at least 10% (NecRatioInc !0.1). Variables measured by contrast-enhanced MRI could be used to evaluate chemotherapy response and increase the limb-salvage rate.
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